Requirement of the MRN complex for ATM activation by DNA damageTamar Uziel, Yosef Shiloh|The EMBO Journal|2003Cited by 1.1k
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren Lasko, Kenneth D. Bromberg, T. Matt Hansen et al.|Nature|2017Cited by 853
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancerEmily J. Faivre, Yu Shen, Keith F. McDaniel et al.|Nature|2020Cited by 404